Kayothera is developing first-in-class small molecule immunotherapies to treat solid cancers

Kayothera is developing first-in-class small molecule immunotherapies to treat solid cancersctschensui2022-12-02T07:07:51+00:00

KayoThera develops first in class precision medicines against solid cancers and other diseases.

Commercial

View Project

Theme-Fusion

DANISH MODERNITY